Munich - Delayed Quote EUR

Elekta AB (publ) (EJX.MU)

Compare
5.35 0.00 (0.00%)
As of 8:00 AM GMT+1. Market Open.

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Dr. Laurent Leksell Founder & Chairman 1.7M -- 1952
Mr. Gustaf Salford President & CEO 12.87M -- 1977
Ms. Caroline Leksell Cooke Senior VP & Head of Neuro Solutions 855k -- 1981
Mr. Tobias Hagglov Chief Financial Officer -- -- 1978
Mr. Peter Nyquist Head of Investor Relations -- -- 1965
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel -- -- 1966
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs -- -- --
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer -- -- 1985
Mr. John Lapré President of Brachy & Neuro Solutions -- -- 1964
Mr. Maurits Wolleswinkel President of Linac & Software Solutions -- -- 1971

Elekta AB (publ)

Hagaplan 4
Box 7593
Stockholm, 113 68
Sweden
46 8 58 72 54 00 https://elekta.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
4,566

Description

Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit; Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Leksell GammaPlan, a treatment planning and management software. In addition, the company offers Elekta ONE, a software suite of multiple Elekta solutions. Further, it provides brachytherapy products, including Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Elekta Xoft Axxent, and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Additionally, the company offers neurosurgery products, such as Leksell Vantage Stereotactic System for intracranial neurosurgery. Furthermore, it provides Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Corporate Governance

Elekta AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 27, 2024 at 10:59 AM UTC

Elekta AB (publ) Earnings Date

Recent Events

September 9, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers